Mar 2025 – Dec 2025 · 9 mos · Beverly, MA

• MantaBio is developing an automated PCR-based bio-burden testing system for biopharma manufacturing. The technology will be a significant improvement in the key needs of speed, ease-of-use, and sensitivity for >95% of microbial contaminants.

Jan 2025 – Present · 1 yr 4 mos · Los Angeles, California, United States · Hybrid

• Cappello Group, Inc. is a 50-year-old global merchant bank and financial advisor to companies, families, and funds, whose principals have conducted over $155 billion in transactions in over 60 countries.

Feb 2004 – Dec 2024 · 20 yrs 10 mos · Los Angeles, California, United States · Hybrid

• Cappello Group, Inc. is a 50-year-old global merchant bank and financial advisor to companies, families, and funds, whose principals have conducted over $155 billion in transactions in over 60 countries.

Jan 2025 – Present · 1 yr 4 mos · Chicago, Illinois, United States · Hybrid

• Non-Profit organization founded by Prescott S. Bush, Jr. to foster relationship between the US and China through increased investment and trade activities between US and China.

Jul 2021 – Present · 4 yrs 10 mos · Houston, Texas, United States

• Emervax is developing circular mRNA vaccines against many of the emerging RNA viral infections that have the potential to cause epidemics or pandemics similar to COVID-19. RNA viruses have caused some of the most severe pandemics of the last 100 years -- influenza, AIDS, dengue, as well as COVID-19, are salient examples. Emervax, based in Houston and founded in 2021, is a spin-out of the University of Texas Medical Branch in Galveston, a leading center for infectious disease research.

Jan 2018 – Present · 8 yrs 4 mos · Houston, Texas, United States · Hybrid

• Autoimmunity Biologic Solutions, Inc. (ABS), founded in 2018, is developing targeted immuno-therapies and diagnostics for treatment of autoimmune diseases and cancers. ABS scientific innovations derive from published and proprietary work of the scientific founders while at ABS, University of Texas Medical Branch Galveston (UTMB) and Duke University. (Gregory et al., 2007, Nature Genetics; Galarza-Muñoz et al., 2017, Cell)

Jun 2017 – Present · 8 yrs 11 mos · Beverly, MA

• Previously called North Shore InnoVentures, InnoVenture Labs is a technology business incubator that for innovative early-stage companies in the biotech and cleantech sectors. Located in Greater Boston, NSIV provides wet-lab facilities, office space, and structured mentoring and education to early-stage companies.
• NSIV was named Incubator of the Year in 2018 by International Business Incubator Association. For more information, please see nsiv.org.

Dec 2013 – Present · 12 yrs 5 mos · Greater Boston Area

• Thrive Bioscience (www.thrivebio.com), based in the Boston area, develops and sells a software platform and automated live cell imaging systems that transform how scientists capture, analyze, and utilize cell-based data.
• Thrive powers data-driven biology by transforming cell behavior into AI-ready, reproducible data and image sets for biologists and data scientists, enabling improved cell-based experiments and processes, stronger computational models, and smarter drug discovery.
• The Thrive IQ software platform and its integrated CellAssist modular family of imaging systems collect images and extract and analyze extensive time-series morphological data and on live cells, colonies, and organoids in one to 50 cell culture plates.

Jan 2012 – Sep 2015 · 3 yrs 8 mos · San Juan, Puerto Rico

• The Founder Institute is an early-stage startup accelerator and global launch network that helps entrepreneurs create meaningful and enduring technology companies. In just over three years of operation, the Founder Institute has helped launch over 650 companies across 40 cities and five continents - making it the world's largest startup accelerator. The Institute's goal is to "Globalize Silicon Valley" by launching 1,000 meaningful and enduring technology companies per year in over 50 cities worldwide.

Dec 2009 – Oct 2011 · 1 yr 10 mos · San Juan, Puerto Rico

• The Trust supports commercialization of technology through technology transfer, seed and venture investments and direct research grants. Additionally, the Trust’s assets include 70 acres in central San Juan that the Trust has been developing into a research park.

Jul 2008 – Feb 2010 · 1 yr 7 mos · Greater Boston Area

• Developer of prostate cancer related diagnostic in clinical trials. ProstaGlove enables the measurement of prostate volume which can be used to calculate PSA Density ("PSAD") a more effective marker than PSA alone for determining which men with elevated PSA should have a prostate biopsy.

Oct 2006 – Jul 2008 · 1 yr 9 mos · Greater Boston Area

• This publicly traded company (NASDAQ: IDEV) as a $100+ million revenues per year specialty pharmaceuticals & device company developing & marketing pharmaceuticals and devices for urologists and endocrinologists. Mr. Farb implemented an innovative and successful strategy of utilizing the 125 person sales force to sell both drugs and devices to the same physician-specialists. The company was acquired by Endo Pharmaceuticals (NASDAQ: ENDP) in 2009.

Jun 2006 – Dec 2008 · 2 yrs 6 mos · Greater Dallas Area

• Developer of medical device for detecting and preventing foreign retained objects resulting from surgery.

Jan 2006 – Sep 2019 · 13 yrs 8 mos · Boston, Massachusetts

Aug 2004 – May 2014 · 9 yrs 9 mos · Shanghai, China

• Through Estabrook Ventures, Mr. Farb has been Co-Founder and/or investor in many companies, established a venture fund. Not active at Estabrook Ventures for period from December 2009 to October 2011 while worked for non-profit (Trust for Science, Technology & Research).

Jan 2004 – Jan 2009 · 5 yrs · Greater Boston Area

Jan 2004 – Jan 2005 · 1 yr · Portland, Oregon Area

• Designer and manufacturer of heritage motorcycles. Also served as Advisor to Board & Consultant to the Company for moving manufacturing to China & for sale of the company.

Sep 2003 – Oct 2006 · 3 yrs 1 mo · Shanghai, China & Greater Boston Area

• Mr. Farb was Managing Director of this private equity/VC firm and co-founded an investment fund with the City of Shanghai & invested in such companies as WuXi Pharmatechs, Shanghai, (NYSE: WU) & ASIMCO, the largest independent manufacturer of auto parts in China. During this period he also co-founded a China/energy focused hedge fund and & co-founded a China-focused investment banking firm.

Jan 2003 – Jan 2009 · 6 yrs · Concord, Massachusetts

Jan 2003 – Jan 2005 · 2 yrs · Minneapolis, MN

• NYSE traded (NYSE: FICO) company which provides analytic, software & data management products to automate & improve business decision-making, including the well known FICO Score used for consumer credit analysis.

Jan 2002 – Sep 2003 · 1 yr 8 mos · Dallas/Fort Worth Area

• This leading manufacturer of digital signage & information systems was merged with RMG Networks and became publicly held in 2013 (NASDAQ: RMGN).

Jan 2002 – Jan 2003 · 1 yr · Minneapolis, MN

• This company(NASDAQ: RETK) was spun off from HNC Software to provide retail analytic, management & supply chain software. Approximately $200 million of revenues when acquired by Oracle in 2005.

Jan 2001 – Jan 2008 · 7 yrs · Concord, Massachusetts

Jan 1995 – Aug 1999 · 4 yrs 7 mos · Greater Chicago Area

• Saf-T-Med designed, received FDA marketing clearance and manufactured specialty medical devices including safety syringes (acquired by Becton Dickinson).

Jan 1994 – Jan 2005 · 11 yrs · San Francisco Bay Area

• A Real Estate Investment Trust (REIT) engaging in residential and commercial mortgage banking activities and investing in mortgage- and other real estate-related assets, principally in California.

Jan 1994 – Jan 1998 · 4 yrs · Greater Boston Area

• Interneuron Pharmaceuticals (NASDAQ: IPIC) developed and marketed drugs for central nervous system (CNS) indications, anti-microbicides (using combinatorial chemistry) and cancer therapeutics (using gene therapies). Mr. Farb was primarily responsible for the operations of the company during its rapid growth period to $75 million in revenues.

Jan 1992 – Jan 1994 · 2 yrs · Greater Boston Area

• A diagnostics and device company which grew to $600 million in revenues, focusing on women’s health until it was acquired by Hologic (NASDAQ: HOLX). While Mr. Farb was at Cytyc the company launched its ThinPrep FDA-approved device for enhanced detection of cervical cancer and he was instrumental in developing the business plan for an applied genomics colon cancer screening test which was spun out and subsequently went public (Exact Sciences, NASDAQ: EXAS).

Jan 1990 – Jan 1992 · 2 yrs · Lexington, MA

Jan 1988 – May 2002 · 14 yrs 4 mos · San Diego, CA

• Provider of real time data analytics for enhanced decision-making with a focus on financial, credit, insurance applications. Publicly traded (NASDAQ: HNCS) with revenues of $~$500 million prior to acquisition by Fair Isaac Corporation (NYSE: FICO).

Jan 1984 – Jan 1990 · 6 yrs · Cambridge, MA

• Publicly traded (NYSE: SMBX) developer & manufacturer of computer systems for use in artificial intelligence (AI) applications.

Jan 1980 – Jan 1984 · 4 yrs · Boston, MA